Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
Hong Kong
· Delayed Price · Currency is HKD 21.80
+1.04 (5.01%)
Mar 10, 2026, 11:51 AM HKT
HKG:2190 Revenue
Zylox-Tonbridge Medical Technology had revenue of 481.97M CNY in the half year ending June 30, 2025, with 109.43% growth. This brings the company's revenue in the last twelve months to 898.46M, up 35.39% year-over-year. In the year 2024, Zylox-Tonbridge Medical Technology had annual revenue of 782.48M with 48.27% growth.
Revenue (ttm)
898.46M CNY
Revenue Growth
+35.39%
P/S Ratio
7.11
Revenue / Employee
1.03M CNY
Employees
875
Market Cap
7.00B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Isotope & Radiation | 8.35B |
| AK Medical Holdings | 1.52B |
| MicroPort NeuroScientific | 807.00M |
| LifeTech Scientific | 1.45B |
| Beijing Chunlizhengda Medical Instruments | 1.16B |
| LEPU ScienTech Medical Technology (Shanghai) | 605.14M |
| MicroPort CardioFlow Medtech | 402.73M |
| Peijia Medical | 731.61M |